{"database": "lobbying", "table": "lobbying_activities", "rows": [[2382227, "31f41b22-53eb-4c63-8400-adf48c815d80", "Q4", "DOTCHIN & ASSOCIATES, LLC", 401105105, "EMERGENT BIOSOLUTIONS", 2019, "fourth_quarter", "DIS", "FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government\nRe-authorization of the Pandemic and All-Hazards Preparedness Act\nNDAA - provisions related to biological and chemical defense", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-15T11:25:14.693000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2382227"], "units": {}, "query_ms": 0.4498769994825125, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}